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Luminescent 1,8-Naphthalimide-Derived ReI 
Complexes: Syntheses, Spectroscopy, X-ray Structure 
and Preliminary Bioimaging in Fission Yeast Cells 
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Abstract: A series of picolyl-functionalised, fluorescent 1,8-
naphthalimide ligands (L) have been synthesised and coordi-
nated to ReI to form luminescent cationic complexes of the 
general form fac-[Re(phen)(CO)3(L)]BF4. The complexes were 
characterised by using a range of spectroscopic and analytical 
techniques. One example of a complex was also characterised 
in the solid-state by using single-crystal X-ray diffraction, reveal-
ing a distorted octahedral coordination sphere at ReI and Re– 
C/Re–N bond lengths within the expected ranges. All ligands 
 
 
 
Introduction 
 
The 1,8-naphthalimide structural motif is a remarkably func-
tional moiety that has found utility in a wide variety of applica-
tions. Such derivatives can be synthesised in a stepwise manner 
allowing control over functionalisation. The electronic proper-ties 
of substituted 1,8-naphthalimides have been utilised in a wide 
range of molecular architectures, from multichromophoric light 
harvesting arrays[1] to the design of fluorescent sensors[2] (for a 
multiplicity of analytes including, metal cations, anions, pH and 
biomolecules). 1,8-Naphthalimide based fluorophores are known 
to possess tuneable emission in the visible region (depending 
upon the nature and position of substituent), to-gether with high 
photostability. For donor functionalised 1,8-naphthalimides, the 
nature of the emitting state is usually an intramolecular charge 
transfer (ICT), which results in solvato-chromic behaviour. The 
fluorescence behaviour of such systems has been successfully 
applied to the design of probes for fluo-rescence cell imaging,[3] 
wherein high quantum yields and large Stokes' shifts are 
advantageous. Beyond their electronic proper- 
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were shown to be fluorescent, with the 4-amino derivatives 
showing intramolecular charge transfer in the visible region 
(511–534 nm). The complexes generally showed a mixture of 
ligand-centred and/or 3MLCT emission depending upon the na-
ture of the coordinated 1,8-naphthalimide ligand. For selected 
complexes, confocal fluorescence microscopy was undertaken 
by using fission yeast cells (Schizosaccharomyces pombe) and 
showed that the structure of the 1,8-naphthalimide ligand influ-
ences the uptake and localisation of the rhenium complex. 
 
 
 
ties, other very important uses for 1,8-naphthalimides include as 
DNA binding probes,[4] and as components of therapeutics (for 
example, amonafide[5]), including those with anticancer[6] 
properties. 1,8-Naphthalimides have also found far-ranging ap-
plication in coordination chemistry,[7] including, for example, in 
the development of tyrosine kinase inhibitors,[8] lanthanide-
based 3D supramolecular frameworks,[9] luminescent lanthan-
ide assemblies,[10] and DNA-interacting organometallics.[11] In 
recent years we have studied the combination of 1,8-naphthal-
imide derived fluorophores with coordination complexes (e.g. 
with AuI) and investigated the resultant species in the context of 
cell imaging studies.[12] Following on from this work we present 
our findings on the development of mixed-ligand ReI complexes 
that incorporate a picolyl-functionalised 1,8-naphthalimide 
ligand. In recent years, organometallic ReI com-plexes have 
shown great utility in bioimaging studies using confocal 
fluorescence microscopy,[13] including examples which 
demonstrate ligand-derived control over intracellular localisa-
tion. Herein, the synthesis and spectroscopic characterisation of 
a series of 1,8-naphthalimide functionalised ligands are de-
scribed, together with their complexation to ReI to form com-
plexes of the type fac-[Re(phen)(CO)3(L)]BF4 (where phen = 
1,10-phenanthroline). Some preliminary cell imaging studies are 
also presented showing the applicability of such systems to bio-
imaging using fluorescence microscopy. 
 
Results and Discussion 
 
Ligand Synthesis and Characterisation 
 
Ligands (L1–7) were isolated, through one or two steps 
(Scheme 1), from commercially available 4-chloro-1,8- 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Synthetic route to the ligands (shown inset) and complexes: (i) 3-picolylamine or 4-picolylamine, EtOH, heat; (ii) piperidine or benzylamine, 
DMSO, heat; (iii) 1,10-phenanthroline, toluene, heat; (iv) AgBF4, MeCN; (v) L1–L7, CHCl3, heat. 
 
naphthalic anhydride. L1[14] has been previously reported. The 
first step involved conversion to 4- or 3-picolyl 4-chloro-substi-
tuted species (L1–3). L2–3 could be further functionalised by 
substitution at the 4-position with either piperidine or benzyl-
amine. Reaction was achieved by heating in DMSO at 70 °C 
with four equivalents of the respective amine. The successful 
formation of L4–7 was easily determined by 1H and 13C{1H} 
NMR spectroscopy. For L6 and L7 there was a characteristic 
NH resonance (broad triplet) at ca. 5.7 ppm. All ligands were 
characterised by high resolution mass spectrometry (HRMS) 
(ES+), showing the [M + H]+ cation peak in all cases. IR spectro-
scopy showed two C=O bands at ca. 1690 and 1650 cm–1, with 
L2–3 having an additional strong peak at ca. 780 cm–1 (C–Cl) 
and L6–7, with a secondary amine, showing the expected peaks 
for the N–H stretch and bend modes ca. 3300 and 1560 cm–1. 
 
Complex Synthesis and Characterisation 
 
The complexes were synthesised (Scheme 1) by heating fac-
[Re(phen)(CO)3(MeCN)]BF4 with the appropriate ligand in 
chloroform under a dinitrogen atmosphere for 12 hours.[15] The ReI 
complexes were fully characterised by 1H and 13C{1H} NMR, IR, 
UV/Vis. spectroscopy and HRMS. 1H NMR spectroscopy re- 
 
vealed a minor shift (ca. 0.2 ppm) of the Nimide–CH2 resonance 
upon coordination to ReI. 13C{1H} NMR spectroscopy distin- 
 
guished the metal bound carbonyls (ca. 185–195 ppm) and li-
gand based C=O resonances (ca. 160 ppm). HRMS (ES+) 
showed a cluster of peaks for the [M]+ ion and also commonly 
[M + MeCN]+. The presence of ReI was confirmed by the 
expected isotopic distribution (185Re, 37.4 %; 187Re 62.6 %). 
Furthermore, IR spectroscopy confirmed the proposed geometry 
with metal carbonyl stretches ca. 2030–1900 cm–1 and a slight 
shift in the imide carbonyl peaks at lower wavenumber values. 
IR spectro-scopy data supported the assignment of an 
approximated C3ν or Cs symmetry at the complex, which predict 
either two or three carbonyl stretches for fac-[Re(CO)3(N^N)(X)] 
complexes. All complexes possessed an additional peak at ca. 
1050 cm–1 as-signed to the BF4– counter anion. 
 
X-ray Crystal Structure of fac-[Re(phen)(CO)3(L4)]BF4 
 
A single-crystal X-ray structure determination was obtained for 
fac-[Re(phen)(CO)3(L4)]BF4 (Figure 1). Orange plate crystals 
were obtained via vapour diffusion of diethyl ether into a con-
centrated MeCN solution of the complex. The data collection 
parameters and refinement details are shown in Table 1; bond 
 
 
  
lengths and bond angles are shown in ESI, Table S1. There are 
four unique complex cation moieties in the asymmetric unit. 
Data analysis confirmed the proposed structure with a slightly 
distorted octahedral coordination geometry for ReI, involving a 
fac-tricarbonyl arrangement, a chelating phenanthroline ligand 
and an axially N-coordinated picolyl-naphthalimide moiety (L4). 
The bond lengths associated with the coordination sphere are 
typical of related ReI complexes.[16] The Re–CO distances lie 
within the range 1.86–1.95(2) Å, whilst the Re–N distances were 
typically longer at 2.173–2.217(14) Å. It is noteworthy that the 
Re–N bond lengths to the axial monodentate pyridine are very 
similar to those associated with the chelating phenanthroline. 
This could be explained by the lack of distortion along the axial 
plane [Cax–Re–Nax 177.4–179.2(6)°] compared to the equatorial 
 
 
 
plane [Ceq–Re–Neq 170.1–173.0(7)° and 175.1–175.6(6)°], 
result-ing in a marginal strengthening of the Re–Npy bond and 
desta-bilisation of the Re–Nphen bond. Interestingly this example 
shows that the naphthalimide unit of L4 is positioned over, and 
relatively co-planar to, the chelating phenanthroline ligand. 
However, this arrangement does not appear to be an intra-
molecular π–π stacking interaction (Cnaph–Cphen 7.26–8.40 Å) 
and likely results from crystal packing effects. 
 
Table 1. Data collection parameters for the X-ray structure of fac-
[Re(phen)(CO)3(L4)]BF4. 
 
 
Formula C38H29BF4N5O5Re 
  
Dcalcd. /g cm–3 1.468 
μ /mm–1 3.020 
Formula weight 908.67 
Colour Orange 
Shape plate 
Size /mm 0.09 × 0.08 × 0.03 
T /K 100(2) 
Crystal system orthorhombic 
Flack parameter 0.220(9) 
Hooft parameter 0.221(4) 
Space group Fdd2 
a /Å 22.9167(16) 
b /Å 51.006(4) 
c /Å 56.261(4) 
α /° 90 
/° 90 
γ /° 90 
V /Å3 65763(8) 
Z 64 
Z′ 4 
Wavelength /Å 0.71075 
Radiation type Mo-Kα Θ
min 
/° 2.345 
Θmax /° 27.481 
Measured refl. 134986 
Independent refl. 37115 
Reflections used 25303 
R
int 0.0799 
Parameters 2128 
Restraints 3130 
Largest peak 2.531 
Deepest hole –1.304 
GooF 1.006 
wR2 (all data) 0.1446 
wR2 0.1269 
R1 (all data) 0.0941 
R1 0.0555 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. X-ray crystal structure of one moiety of fac-
[Re(phen)(CO)3(L4)]BF4 (top) with ellipsoids at 50 % occupancy, and 
(bottom) the four different moie-ties of the asymmetric unit of the 
complex. Solvent, counter anions and hydrogen atoms are omitted. 
 
 
 
Electronic Properties of the Ligands and Complexes 
 
Table 2 shows the UV/Vis. absorption properties of the free li-
gands and complexes. All ligands possessed strong π–π* bands 
below 350 nm (Figure 2). For L1–3, the lowest energy peak is 
vibronically structured and associated with the naphthalimide 
core. The addition of the 4-amino substituent induced an addi-
tional unstructured band around 410–490 nm which is assigned 
to an intramolecular charge transfer (ICT), formally of n-π* char-
acter. The ICT band can be weakened by a lack of planarity 
between the naphthalimide ring and the 4-amino sub-stituent.[17] 
The wavelength of the ICT absorption was batho-chromically 
shifted for the benzylamine derivatives. 
 
 
  
Table 2. Absorption and luminescence properties of the ligands and 
com-plexes. 
 
 
Compound[a] λabs /nm[b] λem /nm[a,c] τ /ns[d] 
L1 344 381 < 1 
L2 340 392 9 
L3 340 392 1 
L4 411 534 < 1 
L5 410 534 < 1 
L6 429 512 10 
L7 428 511 10 
[Re(CO)3(phen)(L1)]BF4 345 528 190 
[Re(CO)3(phen)(L2)]BF4 340 515 4, 40 (60 %) 
[Re(CO)3(phen)(L3)]BF4 340 515 8, 73 (75 %) 
[Re(CO)3(phen)(L4)]BF4 408 537 < 1, 7 (51 %) 
[Re(CO)3(phen)(L5)]BF4 406 534 < 1, 16 (66 %) 
[Re(CO)3(phen)(L6)]BF4 431 514 5, 10 (47 %) 
[Re(CO)3(phen)(L7)]BF4 431 511 < 1, 10 (79 %) 
 
[a] MeCN. [b] Lowest energy absorption. [c] λexc  = 425 nm, 5 × 10–5  M. 
 
[d] λexc = 295 or 459 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A comparison of the UV/Vis. absorption spectra of L5 and fac-
[Re(phen)(CO)3(L5)]BF4. 
 
of solvents of different polarities whereupon the fluorophores 
demonstrated classical positive solvatochromism, as noted in 
our previous work.[12] A comparison of the excitation spectra for 
the different types of ligands showed clear differences. For 
example, comparing L2 and L7 revealed very different excita-
tion profiles with the latter showing a broad peak ca. 440 nm, 
which was assigned to the ICT transition and thus correlates 
relatively well with the observed ICT absorption band (cf. λabs = 
428 nm). Emission lifetime data on L1–7 (Table 2) showed that 
the ligands were fluorescent in all cases (confirming a singlet 
emitting excited state) with lifetimes ≤ 10 ns; it was noted that 
the benzylamine derivatives had the longest lifetimes in the 
series. 
 
 
Figure 2. A comparison of the UV/Vis. absorption spectra for L1, L3, L5 
and L7. 
 
For all ReI complexes the absorption spectra were highly li-
gand dominated with the intense (ca. 10000 M–1 cm–1) ICT tran- 
sition overlapping with the anticipated 1MReLphenCT peak ex-
pected[18] of ReI–phen complexes at 340–400 nm. Furthermore, 
 
the π–π* absorptions < 350 nm possessed higher molar 
absorp-tion coefficients compared to the free ligands due to 
the sum-mative effects of the phenanthroline and 
naphthalimide chromophores (Figure 3). The λmax values for 
the latter show very little variation from the free ligands, 
presumably due to the lack of conjugation between the 
naphthalimide unit and the metal binding site. 
 
Solutions of all ligands were found to be luminescent (Table 
2). Measurements on aerated MeCN solutions of L1–3 resulted 
in a faintly vibronically structured band between 380– 
410 nm (λexc = 345 nm), assigned to a 1π–π* emitting state. For 
the amine-substituted naphthalimides, L4–7, each possessed a 
 
broad, unstructured emission band at 510–530 nm (Figure 4 and 
Table 2). This band is more typical of a donor substituted 
naphthalimide species and consistent with an ICT character. The 
position of the ICT emission was dependent upon the nature of the 
4-amino substituent (Figure 4), with the piperidine vari-ants (L4, L5) 
giving the longest wavelength shift. The ICT nature of the emission 
band was exemplified by measuring in a range 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A comparison of the emission spectra (λexc = 405 nm) of L4 
(red) and L7 (purple). 
 
For the complexes fac-[Re(phen)(CO)3(L1–3)]BF4 excitation 
at 405 nm gave a broad featureless peak ca. 515–528 nm. This 
excitation wavelength correlates with direct population of the 
 
1MReLphenCT band since these complexes lack the naphthal-
imide-localised ICT character. Using higher energy excitation 
 
bands resulted in dual emission for all three complexes. For 
example, Figure 5 shows the excitation wavelength dependent 
emission spectra for fac-[Re(phen)(CO)3(L1)]BF4. With compari-
son to L1, the vibronically structured emission peak at 340– 
 
 
  
440 nm can be attributed to naphthalimide-centred fluores- 
 
cence, whilst the broad peak at 529 nm was assigned to the 
3MReLphenCT transition. The corresponding lifetimes (aerated 
solvent) of these peaks confirm this assignment: with λem = 
 
529 nm, the observed lifetime was 190 ns, which is consistent 
with cationic fac-[Re(phen)(CO)3(L)]+ type complexes,[19] while 
at λem = 385 nm the lifetime was <10 ns.[12] For fac-
[Re(phen)(CO)3(L2)]BF4 and fac-[Re(phen)(CO)3(L3)]BF4 this 
 
3MReLphenCT lifetime was shortened to 40 ns and 73 ns 
respec-tively, suggesting a partial quenching of the excited 
state possi-bly due to the nature of the axial ligand.[15] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Emission spectra showing excitation wavelength dependence of fac-
[Re(phen)(CO)3(L1)]BF4, together with a comparison to L1 (red trace). 
 
For the other complexes in the series there was a close 
corre-lation with the emission wavelengths of the corresponding 
free ligands. Lifetime measurements gave luminescence decay 
pro-files that fitted best to a dual component biexponential, and 
the major contributions from these decays were <20 ns. This 
 
suggests that any 3MReLphenCT character is strongly quenched, 
due to the presence of the substituted naphthalimide ligands. 
 
This might be explained by the partial overlap of the ICT 
naphthalimide absorption band with the expected 3MReLphenCT 
emission profile. In the cases of the benzylamine variants fac- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Comparison of the normalised emission spectra (λexc = 405 
nm) of selected complexes. 
 
[Re(phen)(CO)3(L6)]BF4 and fac-[Re(phen)(CO)3(L7)]BF4, 
the ob-tained lifetimes closely match those for the free 
ligands, sug-gesting 1,8-naphthalimide-dominated 
fluorescence emission for those species (Figure 6). 
 
 
Preliminary Confocal Fluorescence Microscopy 
Imaging with Fission Yeast 
 
The calculated[20] water/octanol partition coefficients (log Pcalc) were 
obtained for the free ligands showing that hydrophobicity increased 
across the series, L1(log Pcalc = 2.42) < L2(2.99) < L3(3.05) < 
L4(3.33) < L5(3.38) < L6(3.57) < L7(3.62). These val-ues predicted 
that addition of either piperidine or benzylamine substituents led to 
the most hydrophobic derivatives; enhanced lipophilicity is a 
common strategy for encouraging cellular uptake of a given agent. 
Preliminary confocal fluorescence mi-croscopy was conducted on a 
selection of complexes to assess their prospective imaging 
capabilities. Complexes were incu-bated with fission yeast cells 
(Schizosaccharomyces pombe). Yeast cell walls typically allow 
translocation of compounds with molecular weights <1000 Da and 
were thus deemed suitable species for probing the fluorophores 
described herein. Cells were imaged by using λexc = 405 nm and a 
detection wave-length window of 500–600 nm. Imaging was initially 
conducted with the 3-picolyl variants fac-[Re(phen)(CO)3(L)]BF4 
species (where L = L1, L3, L4, L5 and L7). Cells were incubated 
with the complexes at a concentration of 10 μg per mL, but resulted 
in very poor observed uptake. An increased probe concentra-tion of 
100 μg per mL generally resulted in much better uptake, although for 
fac-[Re(phen)(CO)3(L3)]BF4 uptake remained poor (only a handful 
of cells were stained), and both fac-[Re(phen)(CO)3(L4)]BF4 and 
fac-[Re(phen)(CO)3(L5)]BF4 showed evidence of precipitate 
formation at these higher concentra-tions. Even though uptake for 
fac-[Re(phen)(CO)3(L1)]BF4 
 
(where emission was dominated by 3MReLphenCT) was judged 
to be relatively modest, good quality cell images were still ob- 
 
tained (Figure 7) showing uptake in both individual and divid-
ing cells. These general observations for limiting uptake has 
been noted previously in yeast imaging work with other ReI– 
diimine complexes incorporating various axial ligands 
(includ-ing those adorned with alkyl chains) that impart 
significantly greater lipophilicity than the complexes 
discussed herein.[21] In those cases a 100 μg per mL 
luminophore concentration was also used for the cell 
incubation work and the complexes were observed to be 
relatively non-toxic with minimal photobleach-ing. 
 
Of the complexes investigated in these bioimaging 
studies, the most lipophilic benzylamine-substituted complex 
fac-[Re(phen)(CO)3(L7)]BF4 showed the best uptake (Figure 
8). Even at 10 μg per mL incubation concentration, it showed 
some cytoplasmic staining and putative mitochondrial 
accumulation. At the higher incubation concentration, 
remarkably detailed im-ages were collected that showed 
clear concentration of the compound in nuclei, particularly in 
dividing cells where two nuclei were present; cell division 
weakens the wall and mem-branes, enhancing their 
permeability and allowing uptake of the fluorophore.[21] 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Confocal fluorescence microscopy of S. pombe yeast cells 
incubated with fac-[Re(phen)(CO)3(L1)]BF4 (λexc = 405 nm; λem = 500–
600 nm) depicted in green; greyscale shows corresponding Nomarski 
D.I.C. transmitted light image. Scalebar in microns. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Confocal fluorescence microscopy of S. pombe yeast cells 
incubated with fac-[Re(phen)(CO)3(L7)]BF4 (λexc = 405 nm; λem = 500–
600 nm) depicted in green; greyscale shows corresponding N omarski 
D.I.C. transmitted light image. Scalebar in microns. 
 
Throughout the duration of the imaging experiments the 
populations of the cells were monitored with respect to an un-
stained control population. For fac-[Re(phen)(CO)3(L1)]BF4 the cell 
populations showed a very good stability perhaps reflecting the 
relatively poor uptake of this agent, whereas cells incubated with 
fac-[Re(phen)(CO)3(L7)]BF4 showed a 47 % drop in popula-tion 
after 4 h. Both complexes also showed a degree of photo- 
 
bleaching which should be noted in future studies and may 
infer some phototoxicity. 
 
 
Conclusions 
 
Picolyl-derived ligands can be adorned with a range of 
naphthalimide derivatives to yield fluorescent species with 
tuneable emission. These ligands coordinate with ReI to give 
mixed ligand species of the form fac-[Re(phen)(CO)3(L)]BF4. 
The resultant complexes were characterised by using a range of 
spectroscopic techniques, and all were found to be lumines- 
 
cent. The origin of the luminescence, be it 3MReLphenCT or 
li-gand-based, varies according to the nature of the specific 
 
naphthalimide ligand. A selection of complexes were chosen 
for cell imaging studies with fission yeast cells (S. pombe), 
and two examples were shown to be viable cell imaging 
agents. Uptake of the complexes appears to be modulated 
by the na-ture of the naphthalimide functionalisation, with the 
most lipo-philic variant showing the best cell uptake. 
 
 
Experimental Section 
 
X-ray Crystallography: Suitable crystals were selected and 
meas-ured following a standard method[22] on a Rigaku AFC12 
goniome-ter equipped with an enhanced sensitivity (HG) 
Saturn724+ detector mounted at the window of a FR-E+ 
SuperBright molybdenum rotat-ing anode generator with VHF 
Varimax optics (70 μm focus) at 100 K. Cell determination, data 
collection, reduction, cell refinement and absorption correction 
carried out by using CrystalClear-SM Ex-pert 3.1b27.[23] 
 
By using Olex2,[24] the structure was solved by charge flipping 
using SUPERFLIP[25] and the models were refined with version 
2014/7 of ShelXL[26] using Least Squares minimisation. All non-
H atoms were refined anisotropically and difference Fourier 
syntheses were em-ployed in positioning idealised hydrogen 
atoms and were allowed to ride on their parent C-atoms. It was 
not possible to accurately model the highly disordered solvent 
and thus PLATON SQUEEZE[27] was used. Disorder in most of 
the BF4 anions, resulting in both geometrical (SAME, BUMP) 
and displacement (RIGU, SIMU) restraints been employed. 
 
Cell Incubation and Confocal Microscopy: The fission yeast 
Schizosaccharomyces pombe 972 h- was grown in 20 mL of 
medium containing glucose (1 %), peptone (1 %), and yeast extract 
(0.3 %) in Ehrlenmeyer flasks shaken at 30 °C for 2 d, when glucose 
utilisa-tion was complete. Washed once in PBS (phosphate-buffered 
saline, pH 7.4) after centrifugation at 1000 g for 2 min, they were 
incubated for 30 min with fluorophores in DMSO with PBS buffer at 
10 and 100 μg per mL (final concentrations in growth medium) at 20 
°C before washing again in PBS. Preparations were viewed by 
epifluo-rescence and transmitted light (Nomarski differential 
interference contrast optics) by using a Leica TCS SP2 AOBS 
confocal laser scan-ning microscope (Leica, Germany) using ×63 or 
×100 objectives, ×4 zoom factor and laser power of 20 %. Excitation 
of the fluorophore was at 405 nm by using a 20 mW diode laser, 
with detection be-tween 500–600 nm. In the majority of cases, initial 
imaging yielded minimal detectable fluorescence so the 
concentration of the fluoro-phore was increased to 100 μg per mL 
final concentration, which was then incubated with the cells at room 
temperature for a further 30 min. 
 
 
 General: 1H and 13C{1H} NMR spectra were recorded on an NMR-FT 
Bruker 400 and 250 MHz spectrometer and recorded in CDCl3. 1H and 
13C{1H} NMR chemical shifts (į) were determined relative to residual 
solvent peaks with digital locking and are given in ppm. Low-resolution 
mass spectra were obtained by the staff at Cardiff University. High-
resolution mass spectra were carried out at the EPSRC National Mass 
Spectrometry Facility at Swansea University. UV/Vis studies were 
performed on a Jasco V-570 spectrophotometer as MeCN solutions (2.5 
or 5 × 10–5 M). Photophysical data were ob-tained on a JobinYvon–
Horiba Fluorolog spectrometer fitted with a JY TBX picosecond 
photodetection module as MeCN solutions. Emission spectra were 
uncorrected and excitation spectra were in-strument corrected. The 
pulsed source was a Nano-LED configured for 459 nm output operating 
at 1 MHz. Luminescence lifetime pro-files were obtained by using the 
JobinYvon–Horiba FluoroHub sin-gle photon counting module and the 
data fits yielded the lifetime values by using the provided DAS6 
deconvolution software. 
 
All reactions were performed with the use of vacuum line and 
Schlenk techniques. Reagents were commercial grade and used 
without further purification. N-(4′-Picolylamine)-1,8-naphthalimide 
(L1)[28] and fac-[Re(phen)(CO)3(MeCN)]BF4[29]were prepared 
accord-ing to the literature. 
 
Synthesis 
 
Synthesis of 4-Chloro-N-(4′-picolylamine)-1,8-naphthalimide 
(L2): Prepared as for L1 but with 4-chloro-1,8-naphthalic anhydride 
(1.997 g, 8.58 mmol) and 4-picolylamine (1.75 mL, 17.2 mmol) to 
give L2 as a yellow solid (yield: 2.216 g, 80 %). 1H NMR (250 MHz, 
CDCl3): įH = 8.71–8.48 (m, 5 H), 7.93–7.78 (m, 2 H), 7.39 (d, 
 
3JHH = 5.7 Hz, 2 H), 5.37 (s, 2 H, CH2) ppm. UV/Vis (CH3CN): λmax 
(İ/M–1 cm–1) = 353 (10800), 340 (12600), 235 (36300), 210 (20100) 
nm. 
 
Synthesis of 4-Chloro-N-(3′-picolylamine)-1,8-naphthalimide 
(L3): Prepared as for L1 but with 4-chloro-1,8-naphthalic anhydride 
(1.975 g, 8.49 mmol) and 3-picolylamine (1.75 mL, 17.2 mmol) to 
give L3 as a yellow solid (yield: 2.444 g, 89 %). 1H NMR (250 MHz, 
CDCl3): įH = 8.76 (d, 3JHH = 1.4 Hz, 1 H), 8.62–8.37 (m, 4 H), 7.86– 
7.70 (m, 3 H), 7.21–7.13 (m, 1 H), 5.30 (s, 2 H, CH2) ppm. 13C{1H} 
NMR (300 MHz, CDCl3): įC = 163.7 (CO), 163.5 (CO), 150.7, 149.0, 
139.5, 137.1, 132.8, 132.4, 131.5, 131.0, 129.4, 127.9, 127.5, 123.5, 
 
122.8, 121.3, 41.3 (CH2) ppm. LRMS (ES+) found m/z 323.06 for [M 
+ H]+, calculated 323.73 for [M + H]+. HRMS (ES+) found m/z = 
323.0583, calculated 323.0582 for [C18 H12N2O2Cl]+. IR (solid): ν˜max = 
 
1697 (C=O), 1655 (C=O), 1616, 1590, 1570, 1505, 1478, 1462, 1400, 
 
1373,  1339,  1316,  1234,  1225,  1173,  1159,  1117,  1094,  1053, 
 
1028, 995, 955, 934, 912, 851, 793, 777 (C–Cl), 752, 733, 714, 667, 
 
623 cm–1. UV/Vis (CH3CN): λmax  (İ/M–1 cm–1) = 353 (13400), 340 
(15600), 235 (52100) nm. 
 
Synthesis of 4-Piperidyl-N-(4′-picolylamine)-1,8-naphthalimide 
(L4): L2 (104 mg, 0.32 mmol) and piperidine (0.13 mL, 1.29 mmol) 
were heated in DMSO (6 mL) under a dinitrogen atmosphere at 80 
°C for 2 h. The solution was cooled and then water was added to 
induce precipitation of the product upon neutralisation with 1 M HCl. 
The solution was then filtered and the solid washed with copi-ous 
amounts of water, followed by petroleum ether, and subse-quently 
dried in vacuo to give L4 as a yellow solid (yield: 86 mg, 
 
72 %). 1H NMR (400 MHz, CDCl3): įH = 8.52 (d, 3JHH = 7.3 Hz, 1 H), 
8.38–8.49 (m, 3 H), 8.34 (d, 3JHH = 8.4 Hz, 1 H), 7.68 (app t, 3JHH = 
7.3 Hz, 2 H), 7.63 (dd, JHH = 8.4, 8.5 Hz, 1 H), 7.32 (d, 3JHH = 5.9 Hz, 
2 H), 7.12 (d, 3JHH = 8.2 Hz, 1 H), 5.30 (s, 2 H, CH2), 3.18 (t, 3JHH = 
5.0 Hz, 4 H, CH2), 1.87–1.72 (m, 4 H, NCH2CH2) ppm. UV/Vis (CH3CN): 
 
λmax (İ/M–1 cm–1) = 411 (10400), 339 (2000), 326 (1900), 275 
(16000), 260 (17900), 225 (25000), 207 (33100) nm. 
 
Synthesis of 4-Piperidyl-N-(3′-picolylamine)-1,8-naphthalimide (L5): 
Prepared as for L4 with L3 (100 mg, 0.31 mmol) and piperidine (0.06 
mL, 0.62 mmol) however in this instance isolation of the pure product 
resulted from extraction of the neutralised reaction mixture into 
dichloromethane (2 × 20 mL). The organic layer was washed with water 
(3 × 20 mL), dried with MgSO4 and reduced to a mini-mum volume. 
Precipitation of the product was then induced via the slow addition of 
petroleum ether. Subsequent filtration and dry-ing in vacuo gave L5 as 
an orange solid (yield: 111 mg, 98 %). 1H NMR (400 MHz, CDCl3): įH = 
8.81 (s, 1 H), 8.53–8.47 (m, 2 H), 8.43 (d, 3JHH = 8.2 Hz, 1 H), 8.34 (d, 
3JHH = 8.4 Hz, 1 H), 8.19 (broad d, 3JHH = 7.9 Hz, 1 H), 7.63 (dd, JHH = 
7.4, 7.3 Hz, 1 H), 7.49–7.42 (m, 1 
 
H), 7.12 (d, 3JHH = 8.2 Hz, 1 H), 5.37 (s, 1 H, CH2), 3.19 (t, 3JHH = 
5.1 Hz, 4 H, CH2), 1.88–1.79 (m, 4 H, CH2CH2), 1.72–1.64 (m, 2 H) 
 
ppm. 13C{1H} NMR (300 MHz, CDCl3): įC = 164.6 (CO), 164.0 (CO), 
157.7, 150.6, 148.8, 136.9, 133.3, 133.1, 131.4, 131.1, 130.0, 126.2, 
 
125.4, 123.4, 122.8, 115.4, 114.8, 54.6, 41.0 (CH2), 26.2, 24.3 ppm. 
LRMS (ES+) found m/z = 372.17 for [M + H]+. HRMS (ES+) found 
m/z = 372.1706, calculated 372.1707 for [C23H22N2O2]+. IR (solid): 
ν˜max = 1688 (C=O), 1645 (C=O), 1584, 1570, 1512, 1481, 1449, 
1429, 1414, 1377 (C–N), 1350, 1339, 1316, 1277, 1250, 1231, 
1219, 1192, 1175, 1153, 1124, 1105, 1076, 1039, 1028, 985, 958, 
939, 897, 864, 843, 814, 779, 758, 741, 712, 665 cm–1. UV/Vis 
(CH3CN): λmax (İ/M–1 cm–1) = 410 (10800), 340 (2500), 325 (2300), 
259 (15900), 224 (24800), 209 (34600) nm. 
 
Synthesis of 4-Benzylamine-N-(4-picolylamine)-1,8-naphthal-imide 
(L6): Prepared as for L5 but with L2 (101 mg, 0.31 mmol) and 
benzylamine (0.10 mL, 0.62 mmol) in DMSO (4 mL), heating for 12 h to 
give L6 as a yellow–orange solid which was recrystallised from 
MeOH/ice cooled petroleum ether (yield: 122 mg, 94 %). 1H NMR (400 
MHz, CDCl3): įH = 8.62 (d, 3JHH = 7.3 Hz, 1 H), 8.52 (d, 3JHH = 5.7 Hz, 1 
H), 8.48 (d, 3JHH = 8.4 Hz, 1 H), 8.17 (d, 3JHH = 8.5 Hz, 1 H), 7.66 (app. 
t, 1 H), 7.55–7.33 (m, 7 H), 6.80 (d, 3JHH = 8.5 Hz, 1 
 
H), 5.68 (t, 3JHH = 5.2 Hz, 1 H, NH), 5.38 (s, 2 H, CH2), 4.64 (d, 3JHH = 
5.1 Hz, 2 H, CH2) ppm. 13C{1H} NMR (300 MHz, CDCl3): įC = 164.6 
 (CO), 164.0 (CO), 149.8, 149.6, 146.8, 137.0, 135.0, 131.7, 130.4, 
130.0, 129.2, 128.2, 127.7, 126.6, 125.1, 123.3, 122.7, 120.4, 110.3, 
105.2, 48.1 (NHCH2), 42.5 (CH2) ppm. LRMS (ES+) found m/z = 394.11 
for [M + H]+. HRMS (ES+) found m/z = 394.1548, calculated 394.1550 
 
for [C25H20O2N3]+. IR (solid): ν˜max = 3300 (N–H), 1684 (C=O), 1643 
(C=O), 1574 (N–H bend), 1539, 1495, 1451, 1416, 1387, 1370, 1341, 
 
1314, 1295, 1242, 1182, 1163, 1130, 1098, 1067, 1028, 991, 979, 
963, 939, 772, 758, 737, 696, 669, 652, 633 cm–1. UV/Vis (CH3CN): 
λmax (İ/M–1 cm–1) = 429 (8100), 353 (3300), 339 (3800), 325 (3200), 
279 (11600), 256 (11600), 229 (16100), 202 (36900) nm. 
 
Synthesis of 4-Benzylamine-(N-3-picolylamine)-1,8-naphthal-
imide (L7): Prepared as for L6 but with L3 (174 mg, 0.54 mmol) and 
benzylamine (0.24 mL, 2.16 mmol) to give L7 as an orange solid 
(yield: 90 mg, 42 %) 1H NMR (400 MHz, CDCl3): įH = 8.74 (s, 1 H), 
8.52 (d, 3JHH = 8.0 Hz, 1 H), 8.36–8.42 (m, 2 H), 8.06 (d, 3JHH = 8.5 
Hz, 1 H), 7.84–7.78 (m, 1 H), 7.53 (dd, JHH = 7.5, 7.3 Hz, 1 H), 
 
7.39–7.24 (m, 5 H), 7.18–7.11 (m, 1 H), 6.68 (d, 3JHH = 8.5 Hz, 1 H), 
5.69 (t, 3JHH = 4.8 Hz, 1 H, NH), 5.29 (s, 2 H, CH2), 4.54 (d, 3JHH = 
5.1 Hz, 2 H, CH2) ppm. 13C{1H} NMR (300 MHz, CDCl3): įC = 164.7 (CO), 
164.0 (CO), 150.6, 149.5, 148.7, 136.9, 136.9, 134.9, 133.6, 131.6, 129.8, 
129.2, 128.2, 127.7, 126.5, 125.0, 123.5, 122.9, 120.4, 110.4, 
105.1, 48.1 (NHCH2), 41.0 (CH2) ppm. LRMS (ES+) found m/z = 394.16 
for [M + H]+. HRMS (ES+) found m/z = 394.1150, calculated 394.1150 
 
for [C25H20N3O2]+. IR (solid): ν˜max = 3350 (N–H), 1734, 1674 (C=O), 
1630 (C=O), 1614, 1576 (N–H bend), 1559, 1516, 1497, 1479, 1451, 
 
1429, 1393, 1369, 1344, 1318, 1298, 1236, 1221, 1186, 1163, 1132, 
 
1120, 1103, 1096, 1065, 1043, 1030, 988, 970, 932, 856, 843, 816, 
 
801, 769, 754, 714, 702, 669, 663 cm–1. UV/Vis (CH3CN): λmax 
 
 
  
(İ/M–1 cm–1) = 428 (12000), 356 (2100), 339 (2400), 324 (2300), 
279 (17100), 258 (16400), 227 (16400), 202 (44000) nm. 
 
Synthesis of fac-[Re(phen)(CO)3(L1)]BF4: fac-[Re(phen)(CO)3-
(MeCN)]BF4 (47 mg, 80.8 μmol) and L1 (26 mg, 88.9 μmol) were 
dissolved in chloroform (3 mL) and heated at reflux, under a dinitro-
gen atmosphere, for 12 h. After cooling the solvent was reduced in 
vacuo. Precipitation of the product was then induced via the slow 
addition of diethyl ether. The product was subsequently filtered and 
dried in vacuo to give the product as an off-white solid (yield: 
 
60.3 mg, 90 %). 1H NMR (400 MHz, CD3CN): įH = 9.45 (dd, JHH = 5.4, 
5.1 Hz, 2 H), 8.92 (dd, JHH = 8.3, 7.8 Hz, 2 H), 8.76–8.73 (m, 1 H), 
 
8.60 (d, 3JHH = 7.3 Hz, 2 H), 8.46 (d, 3JHH = 5.3 Hz, 1 H), 8.40 (d, 3JHH = 
8.2 Hz, 2 H), 8.28 (s, 2 H), 8.10 (dd, JHH = 8.3, 5.1 Hz, 2 H), 7.94–7.90 
(m, 1 H), 7.86 (app. t, 2 H), 7.38 (dd, JHH = 8.2, 4.8 Hz, 1 H), 5.36 (s, 2 
H, CH2) ppm. 13C{1H} NMR (300 MHz, CD3CN): very weak įC = 205.4 
(M–CO), 161.5 (NCCO), 161.3 (NCCO), 154.6, 152.8, 150.2, 148.9, 
140.1, 136.6, 134.5, 131.1, 128.0, 127.2, 125.6, 87.8 (CH2) ppm. LRMS 
(ES+) found m/z = 737.10 for [M]+. HRMS (ES+) found m/z = 737.0953, 
calculated 737.0598 for [C33H20N4O5Re]+. IR (solid): 
ν˜max = (selected) = 2029 (C≡O), 1950 (C≡O), 1907 (C≡O), 1694 
(C=O), 1655 (C=O), 1060 (BF4) cm–1. UV/Vis (CH3CN): λmax (İ/M–1 
cm–1) = 345 (14100), 332 (15900), 273 (43000), 230 (61600), 
210 (46200), 202 (48200) nm. 
 
Synthesis of fac-[Re(phen)(CO)3(L2)]BF4: Prepared as for fac-
[Re(phen)(CO3)(L1)]BF4 with fac-[Re(phen)(CO)3(MeCN)]BF4 (31 mg, 
53.6 μmol) and L2 (19 mg, 59.0 μmol) to give fac-
[Re(phen)(CO3)(L2)]BF4 as a yellow solid (yield: 31 mg, 68 %). 1H NMR 
(400 MHz, CDCl3): įH = 9.46 (dd, JHH = 5.1, 3.8 Hz, 2 H), 8.67 (d, 3JHH = 
7.6 Hz, 2 H), 8.43 (d, 3JHH = 8.5 Hz, 1 H), 8.33 (d, 3JHH = 7.2 Hz, 1 H), 
8.17 (d, 3JHH = 7.9 Hz, 1 H), 8.12–8.06 (m, 2 H), 7.97 (s, 2 H), 8.00–7.92 
(m, 2 H), 7.74–7.69 (m, 2 H), 7.09 (d, 3JHH = 6.6 Hz, 2 H), 4.99 (s, 2 H, 
CH2) ppm. 13C{1H} NMR (300 MHz, CD3CN): įC = 163.4 (CO), 163.2 
(CO), 154.5, 151.9, 150.8, 146.6, 140.3, 140.2, 138.8, 
 
131.9, 131.3, 131.1, 130.8, 129.0, 128.8, 128.3, 128.1, 127.6, 127.1, 
 
125.5, 122.6, 121.3, 118.2, 78.2, 42.1 (CH2) ppm. LRMS (ES+) found 
m/z = 773.21 for [M]+. HRMS (FTMS) found m/z = 771.0567, calcu-lated 
771.0568 for [ReC33H19N4O5Cl]+. IR (solid): ν˜max = (selected) = 2023 
(C≡O), 1903 (C≡O), 1697 (C=O), 1654 (C=O), 1047 (BF4) cm–1. 
 
UV/Vis (CH3CN): λmax (İ/M–1 cm–1) = 353 (16600), 340 (19700), 
327 (17200), 274 (37000), 231 (67200), 213 (66400) nm. 
 
Synthesis of fac-[Re(phen)(CO)3(L3)]BF4: Prepared as for fac-
[Re(phen)(CO)3(L1)]BF4 but with fac-[Re(phen)(CO)3(MeCN)]BF4 (38 
mg, 65.9 μmol) and L3 (25 mg, 73.2 μmol) to give fac-
[Re(phen)(CO)3(L3)]BF4 as a yellow solid (yield: 46 mg, 82 %). 1H NMR 
(400 MHz, CD3CN): įH = 9.42 (d, 3JHH = 3.6 Hz, 2 H), 8.59–8.50 (m, 3 
H), 8.35 (dd, JHH = 7.3, 1.0 Hz, 1 H), 8.26 (d, 3JHH = 5.6 Hz, 1 H), 8.20 
(d, 3JHH = 7.9 Hz, 2 H), 8.01 (d, 3JHH = 1.6 Hz, 1 H), 7.92– 7.81 (m, 7 H), 
7.07 (dd, JHH = 7.8, 5.7 Hz, 1 H), 4.83 (s, 2 H, CH2) ppm. 13C{1H} NMR 
(300 MHz, CD3CN): įC = 195.7 (C≡O), 191.2 (C≡O), 163.2 (CO), 163.0 
(CO), 154.5, 154.4, 152.0, 151.7, 146.5, 140.8, 140.2, 
 
138.9, 136.0, 132.0, 131.2, 130.8, 129.1, 128.8, 128.4, 128.0, 127.7, 
 
127.1, 126.2, 122.6, 121.3, 40.3 (CH2) ppm. LRMS (ES+) found m/z = 
773.12 for [M]+. HRMS (ES+) found m/z = 771.0570, calculated 
 
771.0568 for [C33H19O5N4ClRe]+. IR (solid): ν˜max = (selected) = 2027 
(C≡O), 1928 (C≡O), 1911 (C≡O), 1701 (C=O), 1666 (C=O), 1053 (BF4) 
 
cm–1. UV/Vis (CH3CN): λmax (İ/M–1 cm–1) = 354 (16700), 340 
(19600), 326 (17100), 274 (32200), 233 (62300), 211 (61000) nm. 
 
Synthesis of fac-[Re(phen)(CO)3(L4)]BF4: Prepared as for fac-
[Re(phen)(CO3)(L1)]BF4 with fac-[Re(phen)(CO)3(MeCN)]BF4 (40 mg, 
69.2 μmol) and L4 (28 mg, 76.1 μmol) to give the product as an orange–
yellow solid (yield: 42 mg, 67 %). 1H NMR (400 MHz, CDCl3): įH = 9.50 
(d, 3JHH = 4.6 Hz, 2 H), 8.77 (d, 3JHH = 8.1 Hz, 2 H), 8.34 
 
(d, 3JHH = 6.6 Hz, 1 H), 8.28 (app. t, 2 H), 8.28–8.16 (m, 6 H), 7.55 (app. 
t, 1 H), 7.17 (d, 3JHH = 6.3 Hz, 2 H), 7.04 (d, 3JHH = 8.2 Hz, 1 H), 5.09 (s, 
2 H, CH2), 3.15 (t, 3JHH = 4.6 Hz, 4 H, CH2), 1.86–1.78 (m, 4 
H, CH2), 1.71–1.60 (m, 2 H, CH2) ppm. 13C{1H} NMR (300 MHz, CDCl3): 
 
įC = 195.1 (C≡O), 164.3 (CO), 163.7 (CO), 158.1, 154.3, 153.9, 152.0, 
151.5, 151.3, 146.4, 140.6, 140.6, 133.4, 131.6, 131.4, 130.1, 128.6, 
 
127.7, 126.1, 125.7, 125.4, 122.1, 114.8, 144.4, 52.5, 42.0, 26.1, 
24.3 ppm. LRMS (ES+) found m/z = 822.20 for [M]+. HRMS (ES+) 
found m/z = 820.1690, calculated 820.1693 for [C38H29N5O5Re]+. 
IR (solid): ν˜max = (selected) = 2029 (C≡O), 1911 (C≡O), 1691, 
(C=O), 1654 (C=O), 1051 (BF4) cm–1. UV/Vis (CH3CN): λmax (İ/M–1 
cm–1) = 408 (9700), 340 (5600), 326 (6600), 274 (36700) nm. 
 
Synthesis  of  fac-[Re(phen)(CO)3(L5)]BF4:  Prepared  as  for  fac- 
 
[Re(phen)(CO3)(L1)]BF4 with fac-[Re(phen)(CO)3(MeCN)]BF4 (39 mg, 
67.4 μmol) and L5 (31 mg, 74.1 μmol) to give the product as an 
 
orange solid (yield: 39 mg, 64 %). 1H NMR (400 MHz, CDCl3): įH = 
9.54 (d, 3JHH = 4.6 Hz, 2 H), 8.82–8.76 (m, 2 H), 8.42–8.36 (m, 3 H), 
8.33 (d, 3JHH = 7.9 Hz, 2 H), 8.10–8.01 (m, 5 H), 7.96 (d, 3JHH = 7.9 Hz, 
1 H), 7.73 (app. t, 1 H), 5.02 (s, 2 H, CH2), 3.27 (broad t, 4 H, CH2), 
 
1.94–1.86 (m, 4 H, CH2), 1.80–1.79 (m, 2 H, CH2) ppm. 13C{1H} NMR 
(300 MHz, CDCl3): įC = 195.3 (C≡O), 164.1 (C=O), 153.6, 153.1, 152.5, 
152.3, 151.4, 146.3, 141.2, 140.6, 133.3, 131.8, 131.8, 131.4, 131.4, 
 
128.6, 128.1, 127.5, 127.3, 126.9, 125.8, 125.7, 122.1, 54.8, 54.5, 
40.0, 26.0, 24.1 ppm. LRMS (ES+) found m/z = 822.24 for [M]+. 
HRMS (ES+) found m/z = 820.1691, calculated 820.1693 for 
[C38H29N5O5Re]+. IR (solid): ν˜max = (selected) = 2031 (C≡O), 
1911 (C≡O), 1691 (C=O), 1651 (C=O), 1057 (BF4) cm–1. UV/Vis 
(CH3CN): λmax (İ/M–1 cm–1) = 406 (7000), 274 (34500) nm. 
 
Synthesis  of  fac-[Re(phen)(CO)3(L6)]BF4:  Prepared  as  for  fac- 
 
[Re(phen)(CO3)(L1)]BF4 but with fac-
[Re(phen)(CO)3(MeCN)]BF4 
(38 mg, 65.7 μmol) and L6 (27 mg, 72.3 μmol) to give the product 
 
as a yellow solid (yield: 42 mg, 61 %). 1H NMR (250 MHz, CD3CN): 
įH = 9.60 (d, 3JHH = 5.13 Hz, 2 H), 8.81 (dd, JHH = 7.6, 7.9 Hz, 2 H), 
8.40 (app. t, 2 H), 8.24–8.06 (m, 8 H), 7.65 (t, 3JHH = 8.1 Hz, 1 H), 
7.51–7.32 (m, 4 H), 7.18 (d, 3JHH  = 7.4 Hz, 2 H), 6.98 (t, 1 H, J = 
5.3 Hz, NH), 6.62 (d, 3JHH = 8.0 Hz, 1 H), 5.10 (s, 2 H, CH2), 4.68 (d, 
3JHH = 6.0 Hz, 2 H, CH2) ppm. 13C{1H} NMR (300 MHz, CD3CN): įC = 
 
195.5 (C≡O), 191.5 (C≡O), 164.2 (C=O), 163.1 (C=O), 154.7, 151.7, 
 
150.3, 146.6, 140.3, 138.2, 134.1, 131.3, 131.0, 128.7, 128.1, 127.9, 
 
127.4, 127.2, 127.1, 125.4, 124.7, 122.1, 120.3, 108.8, 104.8, 46.43 
(CH2), 41.6 (NHCH2) ppm. LRMS (ES+) found m/z = 844.24 for 
[M]+. HRMS found m/z = 842.1536, calculated 842.1536 for 
[C40H27N5O5Re]+. IR (solid): ν˜max = (selected) = 2031 (C≡O), 1913 
(C≡O), 1685 (C=O), 1647 (C=O), 1053 (BF4) cm–1. UV/Vis (CH3CN): 
λmax (İ/M–1 cm–1) = 431 (14600), 354 (6900), 337 (9300), 323 
(9600), 275 (47300), 256 (39800), 226 (58400) nm. 
 
Synthesis of fac-[Re(phen)(CO)3(L7)]BF4: Prepared as for fac-
[Re(phen)(CO3)(L1)]BF4 but with fac-[Re(phen)(CO)3(MeCN)]BF4 (42 
mg, 72.1 μmol) and L7 (31 mg, 79.3 μmol) to give the product as a 
yellow solid (yield: 43 mg, 64 %). 1H NMR (400 MHz, CD3CN): įH = 9.39 
(d, 3JHH = 3.8 Hz, 2 H), 8.44 (m, 2 H), 8.32 (d, 3JHH = 4.9 Hz, 2 H), 8.29 
(d, 3JHH = 8.2 Hz, 2 H), 8.02 (d, 3JHH = 8.6 Hz, 1 H), 7.83 (s, 1 H), 7.82–
7.71 (m, 5 H), 7.66 (app. t, 1 H), 7.51 (s, 1 H), 7.41 (d, 3JHH = 7.5 Hz, 2 
H), 7.31 (app. t, 2 H), 7.11 (dd, JHH = 7.7, 5.6 Hz, 1 H), 7.02 (app s, 1 H, 
NH), 6.66 (d, 3JHH = 8.6 Hz, 1 H), 4.83 (s, 2 H, CH2), 4.66 (d, 3JHH = 6.0 
Hz, 2 H, CH2) ppm. 13C{1H} NMR (300 MHz, CD3CN): įC = 195.7 (C≡O), 
191.5 (C≡O), 163.8 (C=O), 162.9 (C=O), 154.3, 151.7, 150.5, 146.3, 
140.3, 139.9, 140.0, 138.3, 137.0, 134.3, 
 
131.2, 131.0, 129.7, 128.7, 128.0, 127.8, 127.4, 127.3, 126.9, 126.1, 
 
124.9, 122.1, 120.7, 120.6, 119.9, 119.1, 105.0, 46.5 (CH2), 39.9 
(NHCH2) ppm. LRMS (ES+) found m/z = 844.16 for [M]+. HRMS 
(FTMS) found m/z 842.1543 for [C40H27N5O5Re]+, calculated 
 
 
  
842.1536 for [C40H27N5O5Re]+. IR (solid): ν˜max = (selected) = 2031 
(C≡O), 1915 (C≡O), 1683 (C=O), 1645 (C=O), 1060 (BF4) cm–1. UV/Vis 
 
(CH3CN): λmax (İ/M–1 cm–1) = 431 (16500), 323 (8300), 275 
(47800), 257 (40800), 226 (53500) nm. 
 
CCDC 1548820 (for C38H29BF4N5O5Re) contains the supplementary 
crystallographic data for this paper. These data can be obtained free of 
charge from The Cambridge Crystallographic Data Centre. 
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